Onkolojide Moleküler Hedefli Tedaviler
Hikmet Taner Teker, Yunus Coşkun, Semiha Urvay, Sinan Kazan(Sağlık Bilimleri Üniversitesi), Müfide Okay, Mürüvvet Akçay Çelik, Özgen Ahmet Yıldırım, Aykut Özmen, Necla Demir, Hakan Keski, Ali Oğul, Selami Bayram, Seher Yıldız Tacar, Muslih Ürün, Yakup Ergün, İbrahim Karadağ, Halil Yıldız(Cliniques Universitaires Saint-Luc), Osman Sütçüoğlu, Gülay Gülbol Duran, Nazan Demir, Mehmet Özgeyik, Hale Önder Yılmaz, Elif Dizen Kazan(Ergani Devlet Hastanesi), Ferit Aslan, Tahir Yerlikaya, Mert Tohumcuoğlu, Mustafa Gürbüz, Ertuğrul Bayram, Işıl Deniz Oğuz, Mustafa Gökoğlu, Sezai Tunç, Seli̇n Aktürk Esen, Okan Avcı, Mahmut Büyükşimşek, İlknur Yurtsever, Gülçin Şahingöz Erdal, Serdar İleri, Gökhan Uçar, Tülay Kuş(Gaziantep University), Canan Karan, Ulaş Işık, Şafak Yıldırım Dişli(Kayseri Eğitim ve Araştırma Hastanesi), Safiye Özkan, Serdar Karakaya, Aylin Güneşli Yetişken, Orhan Kemal Yücel
Cited by 0
Related Papers
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule
|Kidney International|2020|236
Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer
|Annals of Nuclear Medicine|2021|110
<sup>68</sup>Ga-FAPI PET/CT as an Alternative to<sup>18</sup>F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma
|Journal of Nuclear Medicine|2024|58
Serum uric acid, disease severity and outcomes in COVID-19
|Critical Care|2021|41